SCHEMBL9898173

SCHEMBL9898173

CCN(CC)CCO[SiH](OCCN(CC)CC)OCCN(CC)CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.43
MEN1 O00255 2/20 0.43
POLB P06746 1/20 0.43
EBP Q15125 3/20 0.34
SIGMAR1 Q99720 3/20 0.34
CYP2D6 P10635 4/20 0.33
CYP1A2 P05177 2/20 0.33
HTT P42858 2/20 0.33
LTA4H P09960 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
HRH3 Q9Y5N1 2/20 0.32
BIRC5 O15392 1/20 0.32
LMNA P02545 1/20 0.32
CHRNA7 P36544 1/20 0.32
TSHR P16473 1/20 0.32
MAOA P21397 1/20 0.32
HTR3A P46098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9899185 0.87 KMT2A (0.39) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL9898287 0.81 KMT2A (0.41) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL9900027 0.77 HTR1B (0.39) CYP2D6CYP1A2MAPTLMNAKCNH2
SCHEMBL9898378 0.75 MEN1 (0.38) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL2799883 0.74 MEN1 (0.31) KMT2AMEN1POLB
SCHEMBL3000451 0.74 MEN1 (0.36) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL135077 0.73 MEN1 (0.61) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL6697606 0.71
Hydrochloric Acid SCHEMBL11278283 0.71 MEN1 (0.58) KMT2AMEN1POLBEBPSIGMAR1
SCHEMBL1408760 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2471798-B1 PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS BRIDGESTONE CORP (JP) 2015-08-19 EP claimed
EP-2471798-A1 PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS Bridgestone Corporation (JP) 2012-07-04 EP claimed
US-20120149929-A1 PROCESS FOR PRODUCING SILANE COUPLING AGENT BRIDGESTONE CORPORATION (JP) 2012-06-14 US claimed
US-9150595-B2 Process for producing silane coupling agent BRIDGESTONE CORPORATION (JP) 2015-10-06 US disclosed
EP-2471798-B1 PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS BRIDGESTONE CORP (JP) 2015-08-19 EP disclosed
EP-2471798-A1 PROCESS FOR PRODUCTION OF SILANE COUPLING AGENTS Bridgestone Corporation (JP) 2012-07-04 EP disclosed
US-20120149929-A1 PROCESS FOR PRODUCING SILANE COUPLING AGENT BRIDGESTONE CORPORATION (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149929-A1 PROCESS FOR PRODUCING SILANE COUPLING AGENT HAO2, SAMM50, SKP2 KMT2A 299/4885MEN1 3207/4885POLB 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.